The 6 μg-receiving participants showed a trend for a higher seroconversion than the other individuals (98.3%; CI: 94.2–99.5%).
← all excerpts
The immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy individuals: A systematic review and meta-analysis.
1
—
—